Jean-Christophe Renondin
Direttore/Membro del Consiglio presso ABL DIAGNOSTICS
Patrimonio netto: - $ in data 31/05/2024
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Gregory Bailey | M | 68 |
Juvenescence Ltd.
 Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 8 anni |
| Bruno Chalom Sayada | M | - |
Advanced Biological Laboratories SA
 Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | 24 anni |
| Jim Mellon | M | 68 |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 8 anni |
| Alexander Pickett | M | - |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 8 anni |
| Declan Doogan | M | 72 |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 8 anni |
| Deborah Szafir | F | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| J. Ganjei | M | 50 |
Cognate BioServices, Inc.
 Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 13 anni |
| Carlos Freixas | M | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Ronan Boulme | M | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Michael Stella | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 17 anni |
| Noemie Sadoun | F | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Steven H. Kasok | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 4 anni |
| Laure Raffaelli | F | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Alain Leriche | M | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Michael J. Warmuth | M | 61 |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Bertrand Aulong | M | - | - | |
| Lori Noffsinger | F | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 22 anni |
| Scott Law | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 7 anni |
| Evis Hursever | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| David Roblin | M | 57 |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 4 anni |
| Katherine Turner | F | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | 22 anni |
| Daniel Gheza | M | - |
Advanced Biological Laboratories SA
Advanced Biological Laboratories SA Packaged SoftwareTechnology Services Advanced Biological Laboratories SA develops information technology and health solutions for patient management and sequencing data analysis. Its products. Its products are marketed under the brands of TherapyEdge®, ViroScore®, SeqHepB, DeepChek®, VisibleChek®, and HepatiC™. The company was founded by Chalom Bruno Sayada in 2000 and is headquartered in Luxembourg. | - |
| Denham Eke | M | 73 |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | - |
| Roger Kang | M | - |
Cognate BioServices, Inc.
Cognate BioServices, Inc. BiotechnologyHealth Technology Cognate BioServices, Inc. engages in the provision of commercialization services to regenerative medicine, cellular immunotherapy, and cell therapy companies. It offers cGMP clinical and commercial manufacturing; process and assay development and optimization; logistics, supply chain, and manufacturing support services; and clinical, regulatory, and custom services. The company was founded in 2002 and is headquartered in Memphis, TN. | - |
| Richard Marshall | M | 57 |
Juvenescence Ltd.
Juvenescence Ltd. Financial ConglomeratesFinance Juvenescence Ltd. engages in operation as an investment holding company which develops therapeutic products for human ageing and longevity. It provides drug development, new company creation, academic licensing, and biotech investment. The company was founded by James Mellon, Gregory H. Bailey, Declan Dooganin, Alexander Pickett, and Anthony Chow in October 2016 and is headquartered in Liverpool, the United Kingdom. | 1 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Alain Munoz | M | 75 | 19 anni | |
| Peter James Arthur Benson | M | 69 | - | |
| David Solomon | M | 63 | 7 anni | |
| Helle Størum | F | 57 | 9 anni | |
| Jesper Zeuthen | M | - | - | |
| Thomas Tscherning | M | - | 2 anni | |
| Hervé de Kergrohen | M | 66 |
Innovation Capital SASU
 Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | 6 anni |
| Linda Sjöström | F | - | - | |
| Jens W. Kindtler | M | - | - | |
| Rémi Droller | M | 48 | - | |
| Marlene Nørgaard | F | - | - | |
| Franck Noiret | M | 59 |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | 11 anni |
| Florian Reinaud | M | 51 |
Innovation Capital SASU
Innovation Capital SASU Investment ManagersFinance Innovation Capital SASU (Innovation Capital) is the international venture capital subsidiary of CDC Capital Investissement SAS, itself a wholly-owned subsidiary of State-owned CDC Caisse des Dépôts et Consignations in France. Established in 1996 as CDC Entreprises Innovation, the firm was formerly known as CDC Innovation SASU. They changed their name to Innovation Capital SASU in 2012. Located in Paris with representative offices in California and in Switzerland, the firm manages venture capital and innovation mutual funds (FCPRs and FCPIs). Their venture capital funds are sponsored by CDC Capital Investissement, and the innovation funds are generally co-invested with the venture capital funds. The firm's mandate includes public interest missions. | 6 anni |
| Christian Herskind Jørgensen | M | 63 | - | |
| Arvind M. Hundal | M | 61 | - | |
| Hanne Heidenheim Bak | F | 71 | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Danimarca | 13 | 31.71% |
| Francia | 9 | 21.95% |
| Stati Uniti | 9 | 21.95% |
| Lussemburgo | 8 | 19.51% |
| Regno Unito | 7 | 17.07% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jean-Christophe Renondin
- Contatti personali
